Sign in
TOVX Stock Price, Chart, Stats & News
Theriva Biologics, Inc.
Save
Theriva Biologics, Inc. (TOVX) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
TOVX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -6.36% |
ROA | -66.03% |
ROE | -209.36% |
D/E | 0.17x |
Interest coverage ratio | – |
TOVX valuation
P/E | – |
P/S | – |
P/B | 0.16x |
P/CF | -0.15x |
P/FCF | -0.43x |
P/OCF | -0.15x |
PEG | -0.00x |
EV multiple | -1.18x |
About
Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome damage, Clostridioides difficile infection (CDI), the overgrowth of harmful organisms, the rise of antimicrobial resistance (AMR), and acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants.
Similar securities
Based on sector and market capitalization
Report issue